13F HOLDINGS REPORT
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001553936-25-000007
Total Value
$23.6M
Positions
5
Other Managers
0
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ACELYRIN INC (SLRN US) | 00445A100 | 2,906,629 | $7.2M | 30.48% |
| 2 | TAYSHA GENE THERAPIES INC (TSHA US) | TSHA | 3,700,000 | $5.1M | 21.83% |
| 3 | BICYCLE THERAPEUTICS LTD-ADR (BCYC US) | BCYC | 576,343 | $4.9M | 20.77% |
| 4 | FORTE BIOSCIENCES INC (FBRX US) | FBRX | 619,981 | $4.8M | 20.42% |
| 5 | ZENTALIS PHARMACEUTICALS INC (ZNTL US) | ZNTL | 961,486 | $1.5M | 6.49% |